marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-08-2024
Xeris Pharmaceuticals Financial Statements 2011-2024 | XERS
Annual Financial Statements Xeris Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
343 M | 182 M | 188 M | 234 M | 155 M | 180 M | - | - | - | - | - | - | - |
Shares |
138 M | 136 M | 79 M | 46.1 M | 26.1 M | 12 M | - | - | - | - | - | - | - |
Historical Prices |
2.49 | 1.34 | 2.38 | 5.45 | 3.56 | 10 | - | - | - | - | - | - | - |
Net Income |
-62.3 M | -94.7 M | -123 M | -91.1 M | -126 M | -60.1 M | -26.6 M | -13.2 M | - | - | - | - | - |
Revenue |
164 M | 110 M | 49.6 M | 20.4 M | 2.72 M | 2.46 M | 1.56 M | 1.08 M | - | - | - | - | - |
Cost of Revenue |
28.6 M | 22.6 M | 13.3 M | 9.33 M | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 11.1 M | 1.12 M | 2.42 M | 1.55 M | 1.07 M | - | - | - | - | - |
Operating Income |
-44 M | -81.9 M | -115 M | -83.5 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
26.6 M | 14.1 M | 7.18 M | 10.7 M | - | - | - | - | - | - | - | - | - |
EBITDA |
-42.5 M | -80.5 M | -114 M | -82.1 M | -121 M | -59 M | -26.5 M | -13.1 M | - | - | - | - | - |
Operating Expenses |
- | - | - | 94.7 M | 123 M | 61.8 M | 28.2 M | 14.3 M | - | - | - | - | - |
General and Administrative Expenses |
146 M | 138 M | 126 M | 73.7 M | 63.1 M | 21.1 M | 8.02 M | 4.06 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Xeris Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
149 M | 148 M | 141 M | 138 M | 138 M | 137 M | 137 M | 136 M | 136 M | 136 M | 135 M | 125 M | 66.5 M | 66.4 M | 61.2 M | 59.6 M | 46.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-15.7 M | -15 M | -19 M | - | -12.2 M | -19.8 M | -16.8 M | - | -21.8 M | -26.2 M | -33.7 M | - | -26 M | -27.5 M | -18.4 M | - | -16 M | -24.1 M | -29.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
54.3 M | 48.1 M | 40.6 M | - | 48.3 M | 38 M | 33.2 M | - | 29.7 M | 25.3 M | 22.1 M | - | 11.1 M | 8.91 M | 8.2 M | - | 9.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
13.6 M | 7.79 M | 5.97 M | - | 8.2 M | 7.56 M | 5.32 M | - | 5.26 M | 4.81 M | 6.27 M | - | 3.22 M | 3.38 M | 1.83 M | - | 2.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | 7.84 M | - | - | - | 6.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-12.9 M | -8.19 M | -14.2 M | - | -4.91 M | -16 M | -13.3 M | - | -18.8 M | -18.9 M | -29.1 M | - | -24.4 M | -25.8 M | -16.7 M | - | -13.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-6.17 M | -6.07 M | 7.03 M | - | -7.61 M | -4.54 M | 6.22 M | - | 3.99 M | 3.45 M | 3.52 M | - | 1.8 M | 1.8 M | 1.79 M | - | 2.33 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-10.2 M | -5.48 M | -13.9 M | - | -2.2 M | -13.3 M | -12.9 M | - | -16.1 M | -16.2 M | -28.8 M | - | -23.4 M | -25.1 M | -16.4 M | - | -12.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | 32.2 M | - | - | - | 20.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
45 M | 40 M | 38.4 M | - | 37.3 M | 37.6 M | 33.6 M | - | 34.5 M | 33 M | 35.9 M | - | 26.5 M | 25.9 M | 19.1 M | - | 16.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency